Is OPORF or QYLD a better dividend investment in 2026?

OPORF currently yields 3.14% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: QYLD offers higher current income.

What is the dividend yield difference between OPORF and QYLD?

OPORF has a forward dividend yield of 3.14% ($0.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 8.78 percentage points.

Home › Compare › OPORF vs QYLD

OPORF vs QYLD: Dividend Comparison 2026

OPORF yields 3.14% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 QYLD wins by $934.00 in total portfolio value· pulled ahead in Year 10

INVESTMENT

TIME HORIZON10 years

OPORF

● Live price

3.14%

Share price

$0.09

Annual div

$0.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.5K

Annual income

$384.28

Full OPORF calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — OPORF vs QYLD

📍 QYLD pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	OPORF	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, OPORF + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

OPORF pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OPORF

Annual income on $10K today (after 15% tax)

$266.85/yr

After 10yr DRIP, annual income (after tax)

$326.64/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, QYLD beats the other by $4,483.78/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OPORF + QYLD for your $10,000?

OPORF: 50%QYLD: 50%

100% QYLD50/50100% OPORF

Portfolio after 10yr

$24.9K

Annual income

$3,021.80/yr

Blended yield

12.12%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OPORF buys

QYLD buys

No recent congressional trades found for OPORF or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricOPORFQYLD

Forward yield	3.14%	11.92% ✓
Annual dividend / share	$0.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$24.5K	$25.4K ✓
Annual income after 10y	$384.28	$5,659.31 ✓
Total dividends collected	$3.5K	$27.1K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: OPORF vs QYLD ($10,000, DRIP)

Year	OPORF Portfolio	OPORF Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1	$11,014	$313.94	$10,352	$1,192.36	+$662.00 → OPORF
2	$12,108	$323.15	$10,830	$1,347.57	+$1.3K → OPORF
3	$13,288	$332.01	$11,460	$1,539.07	+$1.8K → OPORF
4	$14,558	$340.52	$12,275	$1,777.84	+$2.3K → OPORF
5	$15,926	$348.67	$13,323	$2,078.95	+$2.6K → OPORF
6	$17,397	$356.48	$14,667	$2,463.34	+$2.7K → OPORF
7	$18,979	$363.93	$16,396	$2,960.57	+$2.6K → OPORF
8	$20,679	$371.05	$18,631	$3,612.97	+$2.0K → OPORF
9	$22,504	$377.83	$21,548	$4,482.15	+$956.00 → OPORF
10← crossover	$24,464	$384.28	$25,398	$5,659.31	$934.00 → QYLD

OPORF vs QYLD: Complete Analysis 2026

OPORF — Stock

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, the company is developing a database of infectious disease progression data that include Disease in Motion platform, which comprises unique datasets, such as clinical, immunological, virological, and digital (wearable) biomarkers. The Disease in Motion platform has various potential applications across a range of end users, including big technology, wearables, pharma, and biotech companies. Further, the company provides preclinical and early clinical research services; sales and marketing services; and biometry, data management, and statistics to its various European pharmaceutical clients, as well as drug development consultancy and services, including CMC (chemistry, manufacturing, and controls), and PK and medical writing to a range of European clients. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.

Full OPORF Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this OPORF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OPORF vs SCHD OPORF vs JEPI OPORF vs O OPORF vs KO OPORF vs MAIN OPORF vs XYLD OPORF vs JEPQ OPORF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.